메뉴 건너뛰기




Volumn 13, Issue , 2012, Pages

Biomarkers and cytokines of bone turnover: Extensive evaluation in a cohort of patients with ankylosing spondylitis

Author keywords

Ankylosing spondylitis; Bone mineral density; DKK 1; OPG; RANKL

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; ADALIMUMAB; BIOLOGICAL MARKER; CYTOKINE; DICKKOPF 1 PROTEIN; ETANERCEPT; INFLIXIMAB; NONSTEROID ANTIINFLAMMATORY AGENT; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; SALAZOSULFAPYRIDINE; SCLEROSTIN; SECRETED FRIZZLED RELATED PROTEIN 1; TARTRATE RESISTANT ACID PHOSPHATASE 5; UNCLASSIFIED DRUG;

EID: 84866791414     PISSN: None     EISSN: 14712474     Source Type: Journal    
DOI: 10.1186/1471-2474-13-191     Document Type: Article
Times cited : (87)

References (27)
  • 1
    • 70349582721 scopus 로고    scopus 로고
    • Bone formation versus bone resorption in ankylosing spondylitis
    • 10.1007/978-1-4419-0298-6-8 19731624
    • Bone formation versus bone resorption in ankylosing spondylitis. Schett G, Adv Exp Med Biol 2009 649 114 121 10.1007/978-1-4419-0298-6-8 19731624
    • (2009) Adv Exp Med Biol , vol.649 , pp. 114-121
    • Schett, G.1
  • 2
    • 80054989186 scopus 로고    scopus 로고
    • Osteoporosis: A paradox in ankylosing spondylitis
    • 10.1007/s11914-011-0058-z 21647573
    • Osteoporosis: a paradox in ankylosing spondylitis. Carter S, Lories RJ, Curr Osteoporos Rep 2011 9 112 115 10.1007/s11914-011-0058-z 21647573
    • (2011) Curr Osteoporos Rep , vol.9 , pp. 112-115
    • Carter, S.1    Lories, R.J.2
  • 3
    • 78149468158 scopus 로고    scopus 로고
    • Osteoporosis in ankylosing spondylitis
    • 10.1007/s11926-010-0122-1 20680529
    • Osteoporosis in ankylosing spondylitis. Magrey M, Khan MA, Curr Rheumatol Rep 2010 12 332 336 10.1007/s11926-010-0122-1 20680529
    • (2010) Curr Rheumatol Rep , vol.12 , pp. 332-336
    • Magrey, M.1    Khan, M.A.2
  • 4
    • 35648963790 scopus 로고    scopus 로고
    • Joint remodelling in inflammatory disease
    • 17934094
    • Joint remodelling in inflammatory disease. Schett G, Ann Rheum Dis 2007 66 Suppl 3 ii42 iii44 17934094
    • (2007) Ann Rheum Dis , vol.66 , Issue.SUPPL. 3
    • Schett, G.1
  • 5
    • 51149114022 scopus 로고    scopus 로고
    • The role of Wnt proteins in arthritis
    • 10.1038/ncprheum0881 18756273
    • The role of Wnt proteins in arthritis. Schett G, Zwerina J, David JP, Nat Clin Pract Rheumatol 2008 4 473 480 10.1038/ncprheum0881 18756273
    • (2008) Nat Clin Pract Rheumatol , vol.4 , pp. 473-480
    • Schett, G.1    Zwerina, J.2    David, J.P.3
  • 6
    • 79952113849 scopus 로고    scopus 로고
    • Soluble receptor activator of nuclear factor-kappaB ligand (RANKL) and osteoprotegerin in ankylosing spondylitis: OPG is associated with poor physical mobility and reflects systemic inflammation
    • 10.1007/s10067-010-1543-y 20690034
    • Soluble receptor activator of nuclear factor-kappaB ligand (RANKL) and osteoprotegerin in ankylosing spondylitis: OPG is associated with poor physical mobility and reflects systemic inflammation. Chen CH, Chen HA, Liao HT, Liu CH, Tsai CY, Chou CT, Clin Rheumatol 2010 29 1155 1161 10.1007/s10067-010-1543-y 20690034
    • (2010) Clin Rheumatol , vol.29 , pp. 1155-1161
    • Chen, C.H.1    Chen, H.A.2    Liao, H.T.3    Liu, C.H.4    Tsai, C.Y.5    Chou, C.T.6
  • 8
    • 7544234549 scopus 로고    scopus 로고
    • Evaluation of bone mineral density, hormones, biochemical markers of bone metabolism, and osteoprotegerin serum levels in patients with ankylosing spondylitis
    • Evaluation of bone mineral density, hormones, biochemical markers of bone metabolism, and osteoprotegerin serum levels in patients with ankylosing spondylitis. Franck H, Meurer T, Hofbauer LC, J Rheumatol 2004 31 2236 2241 15517638 (Pubitemid 39453245)
    • (2004) Journal of Rheumatology , vol.31 , Issue.11 , pp. 2236-2241
    • Franck, H.1    Meurer, T.2    Hofbauer, L.C.3
  • 11
    • 33749598017 scopus 로고    scopus 로고
    • Elevated serum levels of soluble receptor activator of nuclear factors-κB ligand (sRANKL) and reduced bone mineral density in patients with ankylosing spondylitis (AS)
    • DOI 10.1093/rheumatology/kel072
    • Elevated serum levels of soluble receptor activator of nuclear factors-kappaB ligand (sRANKL) and reduced bone mineral density in patients with ankylosing spondylitis (AS). Kim HR, Lee SH, Kim HY, Rheumatology 2006 45 1197 1200 10.1093/rheumatology/kel072 16567356 (Pubitemid 44542059)
    • (2006) Rheumatology , vol.45 , Issue.10 , pp. 1197-1200
    • Kim, H.-R.1    Kim, H.-Y.2    Lee, S.-H.3
  • 12
    • 84866250472 scopus 로고    scopus 로고
    • Dickkopf-1 level is lower in patients with ankylosing spondylitis than in healthy people and is not influenced by anti-tumor necrosis factor therapy
    • 10.1007/s00296-011-1981-0 21833531
    • Dickkopf-1 level is lower in patients with ankylosing spondylitis than in healthy people and is not influenced by anti-tumor necrosis factor therapy. Kwon SR, Lim MJ, Suh CH, Park SG, Hong YS, Yoon BY, Kim HA, Choi HJ, Park W, Rheumatol Int 2012 32 8 2523 2527 10.1007/s00296-011-1981-0 21833531
    • (2012) Rheumatol Int , vol.32 , Issue.8 , pp. 2523-2527
    • Kwon, S.R.1    Lim, M.J.2    Suh, C.H.3    Park, S.G.4    Hong, Y.S.5    Yoon, B.Y.6    Kim, H.A.7    Choi, H.J.8    Park, W.9
  • 14
    • 79958131583 scopus 로고    scopus 로고
    • Structural damage in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: Traditional views, novel insights gained from TNF blockade, and concepts for the future
    • 21624183
    • Structural damage in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: traditional views, novel insights gained from TNF blockade, and concepts for the future. Schett G, Coates LC, Ash ZR, Finzel S, Conaghan PG, Arthritis Res Ther 2011 13 Suppl 1 4 21624183
    • (2011) Arthritis Res Ther , vol.13 , Issue.SUPPL. 1 , pp. 194
    • Schett, G.1    Coates, L.C.2    Ash, Z.R.3    Finzel, S.4    Conaghan, P.G.5
  • 15
    • 79953205984 scopus 로고    scopus 로고
    • Structural bone changes in spondyloarthritis: Mechanisms, clinical impact and therapeutic considerations
    • 10.1097/MAJ.0b013e31820f8b29 21358309
    • Structural bone changes in spondyloarthritis: mechanisms, clinical impact and therapeutic considerations. Schett G, Am J Med Sci 2011 341 4 269 271 10.1097/MAJ.0b013e31820f8b29 21358309
    • (2011) Am J Med Sci , vol.341 , Issue.4 , pp. 269-271
    • Schett, G.1
  • 16
    • 0021272107 scopus 로고
    • Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria
    • Evaluation of diagnostic criteria for ankylosing spondylitis. a proposal for modification of the New York criteria. van der Linden S, Valkenburg HA, Cats A, Arthritis Rheum 1984 27 361 368 10.1002/art.1780270401 6231933 (Pubitemid 14134775)
    • (1984) Arthritis and Rheumatism , vol.27 , Issue.4 , pp. 361-368
    • Van Der Linden, S.1    Valkenburg, H.A.2    Cats, A.3
  • 18
    • 0032437879 scopus 로고    scopus 로고
    • The Bath Ankylosing Spondylitis Radiology Index (BASRI): A new, validated approach to disease assessment
    • DOI 10.1002/1529-0131(199812)41:12<2263::AID-ART23>3.0.CO;2-I
    • The Bath Ankylosing Spondylitis Radiology Index (BASRI): a new, validated approach to disease assessment. MacKay K, Mack C, Brophy S, Calin A, Arthritis Rheum 1998 41 2263 2270 10.1002/1529-0131(199812)41:12<2263::AID-ART23>3. 0.CO;2-I 9870884 (Pubitemid 29009386)
    • (1998) Arthritis and Rheumatism , vol.41 , Issue.12 , pp. 2263-2270
    • Mackay, K.1    Mack, C.2    Brophy, S.3    Calin, A.4
  • 19
    • 0028579768 scopus 로고
    • A new approach to defining functional ability in ankylosing spondylitis: The development of the Bath Ankylosing Spondylitis Functional Index
    • 7699629
    • A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. Calin A, Garrett S, Whitelock H, Kennedy LG, O'Hea J, Mallori P, Jenkinson T, J Rheumatol 1994 21 2281 2285 7699629
    • (1994) J Rheumatol , vol.21 , pp. 2281-2285
    • Calin, A.1    Garrett, S.2    Whitelock, H.3    Kennedy, L.G.4    O'Hea, J.5    Mallori, P.6    Jenkinson, T.7
  • 20
    • 0028575453 scopus 로고
    • A new approach to defining disease status in ankylosing spondylitis: The Bath Ankylosing Spondylitis Disease Activity Index
    • 7699630
    • A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A, J Rheumatol 1994 21 2286 2291 7699630
    • (1994) J Rheumatol , vol.21 , pp. 2286-2291
    • Garrett, S.1    Jenkinson, T.2    Kennedy, L.G.3    Whitelock, H.4    Gaisford, P.5    Calin, A.6
  • 23
    • 73249137735 scopus 로고    scopus 로고
    • Bone remodeling in rheumatic disease: A question of balance
    • 10.1111/j.0105-2896.2009.00857.x 20193007
    • Bone remodeling in rheumatic disease: a question of balance. Walsh NC, Gravallese EM, Immunol Rev 2010 233 301 312 10.1111/j.0105-2896.2009.00857.x 20193007
    • (2010) Immunol Rev , vol.233 , pp. 301-312
    • Walsh, N.C.1    Gravallese, E.M.2
  • 24
    • 34547943895 scopus 로고    scopus 로고
    • Changes of clinical response and bone biochemical markers in patients with ankylosing spondylitis taking etanercept
    • 17610317
    • Changes of clinical response and bone biochemical markers in patients with ankylosing spondylitis taking etanercept. Woo JH, Lee HJ, Sung IH, Kim TH, J Rheumatol 2007 34 1753 1759 17610317
    • (2007) J Rheumatol , vol.34 , pp. 1753-1759
    • Woo, J.H.1    Lee, H.J.2    Sung, I.H.3    Kim, T.H.4
  • 25
    • 60549102695 scopus 로고    scopus 로고
    • Osteoimmunology in rheumatic diseases
    • 10.1186/ar2571 19232069
    • Osteoimmunology in rheumatic diseases. Schett G, Arthritis Res Ther 2009 11 210 10.1186/ar2571 19232069
    • (2009) Arthritis Res Ther , vol.11 , pp. 210
    • Schett, G.1
  • 27
    • 35348917781 scopus 로고    scopus 로고
    • Wnt signaling antagonists are potential prognostic biomarkers for the progression of radiographic hip osteoarthritis in elderly Caucasian women
    • DOI 10.1002/art.22867
    • Wnt signaling antagonists are potential prognostic biomarkers for the progression of radiographic hip osteoarthritis in elderly Caucasian women. Lane EN, Nevitt MC, Lui LY, de Leon P, Corr M, Arthritis Rheum 2007 56 3319 3325 10.1002/art.22867 17907185 (Pubitemid 47585426)
    • (2007) Arthritis and Rheumatism , vol.56 , Issue.10 , pp. 3319-3325
    • Lane, N.E.1    Nevitt, M.C.2    Lui, L.-Y.3    De Leon, P.4    Corr, M.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.